1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.93%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-34.20%
Negative gross profit growth while WEED.TO is at 178.59%. Joel Greenblatt would examine cost competitiveness or demand decline.
61.81%
EBIT growth above 1.5x WEED.TO's 36.94%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
61.81%
Operating income growth above 1.5x WEED.TO's 36.94%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
53.38%
Positive net income growth while WEED.TO is negative. John Neff might see a big relative performance advantage.
55.11%
Positive EPS growth while WEED.TO is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
55.11%
Positive diluted EPS growth while WEED.TO is negative. John Neff might view this as a strong relative advantage in controlling dilution.
5.26%
Slight or no buybacks while WEED.TO is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
5.26%
Slight or no buyback while WEED.TO is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
-136.34%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-164.10%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
No Data
No Data available this quarter, please select a different quarter.
373.08%
5Y revenue/share CAGR above 1.5x WEED.TO's 220.23%. David Dodd would look for consistent product or market expansions fueling outperformance.
-43.99%
Negative 3Y CAGR while WEED.TO stands at 135.59%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-41900.71%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
60.67%
Positive OCF/share growth while WEED.TO is negative. John Neff might see a comparative advantage in operational cash viability.
89.54%
Positive 3Y OCF/share CAGR while WEED.TO is negative. John Neff might see a big short-term edge in operational efficiency.
-3781.62%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-193.75%
Negative 5Y net income/share CAGR while WEED.TO is 56.64%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-402.19%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
5906.98%
10Y equity/share CAGR above 1.5x WEED.TO's 995.41%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
-16.70%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-14.43%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4.81%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
15.72%
Inventory growth well above WEED.TO's 9.35%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
2.21%
Positive asset growth while WEED.TO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-2.95%
We have a declining book value while WEED.TO shows 20.26%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-4.65%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-56.11%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-13.48%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.